These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 5603007

  • 1. [Autonomous treatment of pulmonary tuberculosis with delayed-action drugs].
    Pannain M, Tarantino AB, Mac Dowell A, Costa JA, Cunha JM, Pantoja W.
    Rev Bras Med; 1967 Aug; 24(8):664-8. PubMed ID: 5603007
    [No Abstract] [Full Text] [Related]

  • 2. [Preparations of the 2d series in the complex treatment of middle-aged and elderly patients with pulmonary tuberculosis].
    Iaschenko BP.
    Probl Tuberk; 1967 Aug; 45(9):21-6. PubMed ID: 4303748
    [No Abstract] [Full Text] [Related]

  • 3. [Immediate results of treatment of tuberculosis patients with drugs of the second series].
    Ivanova ES, Komarova AA.
    Sov Med; 1967 Jun; 30(6):107-10. PubMed ID: 5611339
    [No Abstract] [Full Text] [Related]

  • 4. [Evaluation of the therapeutic effects of secondary antitubercular agents].
    Watanabe S, Nosaki M, Iwasaki M, Hamano S, Furuya Y.
    Iryo; 1966 Mar; 20(3):251-6. PubMed ID: 5965119
    [No Abstract] [Full Text] [Related]

  • 5. [Therapy of pulmonary tuberculosis in its current aspects].
    Gartmann JC.
    Bibl Tuberc; 1965 Mar; 20():59-70. PubMed ID: 4291161
    [No Abstract] [Full Text] [Related]

  • 6. [Experience in treatment of patients with chronic destructive pulmonary tuberculosis in a suburban tuberculosis hospital].
    Sirota DS, Man'kovetskiĭ EF, Koĭfman SG, Vatsyk MZ.
    Probl Tuberk; 1974 Mar; (10):17-9. PubMed ID: 4370967
    [No Abstract] [Full Text] [Related]

  • 7. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA, Utkin VV, Korotaev GA, Golitsina LV.
    Probl Tuberk; 1967 Mar; 45(5):29-33. PubMed ID: 5617941
    [No Abstract] [Full Text] [Related]

  • 8. [Clinical problems of resistance to secondary antitubercular agents].
    Baba H, Takahashi R, Nakai T, Torii R, Yo I.
    Iryo; 1966 Mar; 20(3):230-40. PubMed ID: 5964830
    [No Abstract] [Full Text] [Related]

  • 9. [Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis].
    Mamolat AS, Bialik IB, Khutorskaia VD.
    Klin Med (Mosk); 1976 Dec; 54(12):72-8. PubMed ID: 189127
    [No Abstract] [Full Text] [Related]

  • 10. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M, Izumi K, Kamima H, Hirose H, Saito M.
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract] [Full Text] [Related]

  • 11. The treatment of drug resistant chronic pulmonary tuberculosis with new tuberculostatics.
    Zierski M.
    Bull Int Union Tuberc; 1968 Dec; 41():194-200. PubMed ID: 4303863
    [No Abstract] [Full Text] [Related]

  • 12. Treatment of pulmonary tuberculosis with ethionamide, cycloserine and pyrazinamide in Hong Kong.
    Horsfall PA.
    Bull Int Union Tuberc; 1972 Aug; 47 Suppl 2():91-100. PubMed ID: 4662516
    [No Abstract] [Full Text] [Related]

  • 13. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K, Hayashida M, Ishihara M, Ijichi F, Obata Y.
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract] [Full Text] [Related]

  • 14. Chemotherapy of tuberculosis.
    Lester W.
    Clin Notes Respir Dis; 1970 Mar; 9(2):3-13. PubMed ID: 4319281
    [No Abstract] [Full Text] [Related]

  • 15. [Triple reserved scheme in the treatment of resistent forms of pulmonary tuberculosis (preliminary results)].
    Rizzo A, Magalhães M, Moura N.
    Rev Bras Med; 1969 Sep; 26(9):504-10. PubMed ID: 5381888
    [No Abstract] [Full Text] [Related]

  • 16. [Triple drug regimen with reserve drugs: ETA, PZA and CS in the treatment of chronic pulmonary tuberculosis].
    Wagner J.
    Gruzlica; 1966 Mar; 34(3):249-54. PubMed ID: 5947778
    [No Abstract] [Full Text] [Related]

  • 17. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
    Bialik IB.
    Antibiotiki; 1971 Feb; 16(2):184-8. PubMed ID: 4326728
    [No Abstract] [Full Text] [Related]

  • 18. [Therapy of pulmonary tuberculosis with reserve drugs in the light of our personal observations].
    Kochnowski G.
    Wiad Lek; 1970 Jan 01; 23(1):9-13. PubMed ID: 4312765
    [No Abstract] [Full Text] [Related]

  • 19. [Results of treatment with a combined 3-drug regimen of secondary drugs in chronic cavernous pulmonary tuberculosis. A study under auspices of the International Union against Tuberculosis].
    Zierski M, Zacara A, Woźniak S.
    Gruzlica; 1968 Sep 01; 36(9):809-18. PubMed ID: 4882450
    [No Abstract] [Full Text] [Related]

  • 20. Efficacy and safety of kanamycin, ethionamide, PAS and cycloserine in multidrug-resistant pulmonary tuberculosis patients.
    Prasad R, Verma SK, Sahai S, Kumar S, Jain A.
    Indian J Chest Dis Allied Sci; 2006 Sep 01; 48(3):183-6. PubMed ID: 18610675
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.